Condition branding: naming a market into being

Schematic diagram: Condition branding: naming a market into being

Cause branding, in its medical form, is the work of building a recognizable identity around a condition so that the condition itself becomes something people can name, discuss and seek treatment for. Condition branding is the sharpest version of this: giving a vague or common complaint a memorable name, and sometimes an acronym, so that a market exists for a product before, or exactly as, that product arrives. In plain terms, a name is created for a cluster of symptoms, the name makes the condition feel real and definite, and a treatment then has an obvious target. This page explains the technique neutrally as a matter of marketing practice and critique. It is not medical advice, and it does not suggest that any named condition is imaginary.

How a name precedes a drug

Ordinary experiences are fuzzy. Tiredness, low desire, restlessness, worry and mild forgetfulness shade into one another and into normal life. A brand imposes an edge. Once a set of feelings has a fixed clinical label, it stops being a passing mood and becomes a thing a person either has or does not have, and things that can be diagnosed can be treated. The industry writer Vince Parry described this openly in a 2003 trade article on the art of branding a condition, distinguishing three approaches: encouraging acceptance of an unbranded condition already recognized by doctors, redefining an existing condition to fit a new drug, and developing a new condition from a collection of symptoms. In each case the label does marketing work that no product advertisement could, because it reshapes how people understand their own bodies.

The technique is older than modern pharmaceuticals. In the 1920s a mouthwash company popularized “halitosis,” a little-used medical word for bad breath, and turned an unremarkable fact of life into a socially urgent condition its product could fix. The structure is identical to later examples: name the problem, make it feel like a defect, offer the remedy.

The characteristics of a well-branded condition

Marketers and their critics broadly agree on what makes a condition brand effective, even if they disagree about whether any given case is justified. A strong condition brand tends to share several characteristics.

  • A memorable, non-threatening name or acronym. “Low T” for low testosterone is easier to say and to own than a clinical description of androgen decline, and it fits neatly beside a branded product.
  • A broad, relatable symptom set. The wider and more ordinary the symptoms, the more people will recognize themselves in the description.
  • A number or test that draws a line. A threshold turns a spectrum into a diagnosis, as with bone density and osteopenia.
  • An available treatment. Conditions with a marketable remedy attract far more branding effort than those without one.
  • A story of neglect. Framing the condition as long overlooked lends the campaign the credibility of a public cause.

Restless legs syndrome, female sexual dysfunction and social anxiety disorder are all frequently cited in the academic literature as conditions whose public profiles rose sharply alongside the marketing of a treatment. In each case the point of the critique is not that the underlying experience is fake but that its boundary, its name and its prominence were commercially shaped.

Why companies invest in branding a condition

The logic is straightforward. A company that has spent heavily to develop a medicine needs enough diagnosed patients to recover that investment. If the relevant condition is narrowly defined or poorly recognized, the market is small; if it is widely recognized, the market is large. Branding the condition is therefore a way to grow demand at its source, upstream of any individual sale. Because a condition, unlike a molecule, cannot be patented, this kind of promotion also benefits every maker of a similar product, which is one reason awareness of a category can be cultivated jointly across an industry through shared campaigns and conferences.

Condition branding versus research and development

It is worth distinguishing this activity from the science that produces medicines in the first place. Research and development is the laboratory and clinical work of discovering a compound, testing it for safety and effect, and securing approval. Marketing, including condition branding, is the downstream work of creating and capturing demand for what R&D produced. The two are different in character and often in the personnel and budgets assigned to them.

Research and developmentCondition branding (marketing)
GoalDiscover and prove a treatment works and is safeBuild recognition and demand for the condition it treats
OutputA tested compound and regulatory approvalA named, recognized condition and a market
Governed byTrial evidence and regulatorsPromotional rules and, for unbranded work, few of them
Main risk to the publicAn unsafe or ineffective drug reaching patientsA widened definition drawing in people unlikely to benefit

The distinction matters because the two are sometimes conflated in defense of the industry: heavy promotion is justified by the cost of discovery. Critics such as Ray Moynihan and Alan Cassels, authors of the 2005 book Selling Sickness, accept that discovery is expensive and valuable while arguing that branding a condition can outrun the evidence, extending a diagnosis to people for whom the tested benefit was never demonstrated.

Reading a branded condition fairly

None of this means a named condition is false or that a diagnosis should be doubted. Many branded conditions describe real and sometimes severe problems, and a clear name can help patients get recognition and care they were previously denied. The fair reading holds two ideas at once: the experience can be genuine, and its definition can still be commercially influenced. When a new condition appears in public awareness with a tidy name, a broad checklist and a ready treatment, that combination is a signal to look at how the boundary was drawn and by whom, not a reason to dismiss anyone’s symptoms.

Where to go next